• Citer

Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.

par Knoop, Christiane ;Kentos, Alain ;Remmelink, Myriam ;Garbar, Christian;Goldman, Serge ;Feremans, Walter ;Estenne, Marc
Référence Clinical transplantation, 20, 2, page (179-187)
Publication Publié, 2006

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
Auteur:	Knoop, Christiane; Kentos, Alain; Remmelink, Myriam; Garbar, Christian; Goldman, Serge; Feremans, Walter; Estenne, Marc
Informations sur la publication:	Clinical transplantation, 20, 2, page (179-187)
Statut de publication:	Publié, 2006
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Anti-CD20 monoclonal antibody
	Lung transplantation
	PTLD
MeSH keywords:	Adult
	Antibodies, Monoclonal -- therapeutic use
	Female
	Humans
	Immunologic Factors -- therapeutic use
	Immunosuppression -- methods
	Lung Transplantation -- adverse effects
	Lung Transplantation -- immunology
	Lymphoproliferative Disorders -- drug therapy
	Lymphoproliferative Disorders -- immunology
	Lymphoproliferative Disorders -- physiopathology
	Male
	Middle Aged
	Postoperative Complications -- therapy
Note générale:	Case Reports
	Journal Article
	FLWIN
Langue:	Anglais
Identificateurs:	urn:issn:0902-0063
	info:doi/10.1111/j.1399-0012.2005.00462.x
	info:pii/CTR462
	info:scp/33646036687
	info:pmid/16640524